We bring you the latest news from the healthcare about the health care in the United Kingdom.

vrijdag 9 maart 2018

Oncogene - Table of Contents alert Volume 37 Issue 10

If you are unable to see the message below, click here to view.

Volume 37, Issue 10

In this issue
Review Article
Brief Communications
Also new

Review Article

Protein kinase D2: a versatile player in cancer biology

Ninel Azoitei, Mathias Cobbaut, Alexander Becher, Johan Van Lint & Thomas Seufferlein

Oncogene 2017 37 :1263 - 1278; December 20, 2017; 10.1038/s41388-017-0052-8


Abstract | Full Text


Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1

Noriaki Tanaka, Mei Zhao, Lin Tang, Ameeta A. Patel, Qing Xi et al.

Oncogene 2017 37 :1279 - 1292; December 22, 2017; 10.1038/s41388-017-0032-z


Abstract | Full Text

Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis

Lan Ding, Yanqing Zhang, Lingling Han, Lei Fu, Xia Mei et al.

Oncogene 2017 37 :1293 - 1307; December 29, 2017; 10.1038/s41388-017-0055-5


Abstract | Full Text

A CREB3-regulated ER–Golgi trafficking signature promotes metastatic progression in breast cancer

Breege V. Howley, Laura A. Link, Simon Grelet, Maya El-Sabban & Philip H. Howe

Oncogene 2017 37 :1308 - 1325; December 18, 2017; 10.1038/s41388-017-0023-0


Abstract | Full Text

DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7

Sue Jin Moon, Byong Chang Jeong, Hwa Jin Kim, Joung Eun Lim, Ghee Young Kwon et al.

Oncogene 2017 37 :1326 - 1339; December 18, 2017; 10.1038/s41388-017-0047-5


Abstract | Full Text

GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers

Suhail Ahmed Kabeer Rasheed, Hui Sun Leong, Manikandan Lakshmanan, Anandhkumar Raju, Dhivya Dadlani et al.

Oncogene 2017 37 :1340 - 1353; December 19, 2017; 10.1038/s41388-017-0038-6


Abstract | Full Text

Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4

Shidong Lv, Liyan Ji, Bin Chen, Shuqiang Liu, Chengyong Lei et al.

Oncogene 2017 37 :1354 - 1368; December 22, 2017; 10.1038/s41388-017-0026-x


Abstract | Full Text

HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome

Simona di Martino, Carla Azzurra Amoreo, Barbara Nuvoli, Rossella Galati, Sabrina Strano et al.

Oncogene 2018 37 :1369 - 1385; January 09, 2018; 10.1038/s41388-017-0044-8


Abstract | Full Text

FHL2 interacts with EGFR to promote glioblastoma growth

Lili Sun, Shuye Yu, Hui Xu, Yanwen Zheng, Juntang Lin et al.

Oncogene 2018 37 :1386 - 1398; January 11, 2018; 10.1038/s41388-017-0068-0


Abstract | Full Text

Brief Communications

FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer

Bingchen Han, Bo Zhou, Ying Qu, Bowen Gao, Yali Xu et al.

Oncogene 2017 37 :1399 - 1408; December 18, 2017; 10.1038/s41388-017-0021-2


Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature